Products for Research Use Only
RegisterLogin

Polatuzumab

CAT: 0804-HY-P99042-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99042-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Polatuzumab is a monoclonal antibody that targets CD79b on the surface of B cells. Polatuzumab can be used to synthesize the ADC Polatuzumab Vedotin , which has anti-tumor activity[1].
CAS Number
2279068-37-8
UNSPSC
12352203
Target
ADC Antibody; Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/polatuzumab.html
Purity
99.69
Solubility
H2O
Smiles
[Polatuzumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Estelle Bourbon, et al. Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma. Expert Opin Investig Drugs. 2020 Oct;29 (10) :1079-1088.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
BA2315-10Polatuzumab
GTR18320576-01Polatuzumab Antibody
T77823-01Polatuzumab vedotin
CBA1071-01Polatuzumab Biosimilar
DW431028Polatuzumab ELISA Kit
WA3373Research Grade Polatuzumab
D4012-01Polatuzumab vedotin-piiq
A2550-1mg*25Polatuzumab (Anti-CD79b)
047708CD79b (polatuzumab) discontinued
E55B0741Polatuzumab (Reference antibody)

Popular Products